Anastrozole
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (National)
515.4K
NHS Cost
£996.6K
Practices
5,660
Avg per Practice
91
Overview
Anastrozole is prescribed by 5,660 GP practices across England. In the last 12 months, 515,377 items were prescribed at a total cost of £996,601 to the NHS. It is classified under BNF Chapter Malignant Disease and Immunosuppression, Section Sex hormones and hormone antagonists in malignant disease.
Monthly Prescribing Trend
Jun 2026
39,974
Jun 2026
36,958
Jun 2026
40,210
Jun 2026
38,958
Jun 2026
37,584
Jun 2026
39,578
Jun 2026
37,910
Jun 2026
38,917
Jun 2026
39,130
Jun 2026
34,942
Jun 2026
37,246
Jun 2026
37,126
Prescribing by Area
| Area | Items | Practices | Avg/Practice | vs National |
|---|---|---|---|---|
| B | 21.3K | 237 | 90 | -1.4% vs avg |
| PE | 20.5K | 89 | 231 | +153.5% ▲ |
| ST | 18.4K | 83 | 221 | +142.8% ▲ |
| RG | 18.3K | 65 | 282 | +209.1% ▲ |
| NG | 17.2K | 134 | 129 | +41.3% ▲ |
| LS | 16.0K | 85 | 188 | +106.4% ▲ |
| GL | 15.6K | 65 | 240 | +163.9% ▲ |
| DE | 13.3K | 80 | 167 | +83.2% ▲ |
| SN | 12.1K | 45 | 270 | +196.3% ▲ |
| OX | 12.0K | 57 | 210 | +131.0% ▲ |
| YO | 11.7K | 46 | 254 | +179.0% ▲ |
| EX | 10.8K | 60 | 180 | +98.0% ▲ |
| CT | 10.6K | 48 | 221 | +142.8% ▲ |
| NN | 10.6K | 63 | 168 | +84.4% ▲ |
| WF | 10.5K | 59 | 177 | +94.7% ▲ |
| NR | 9,769 | 73 | 134 | +46.9% ▲ |
| BD | 9,400 | 55 | 171 | +87.6% ▲ |
| WR | 8,822 | 31 | 285 | +212.4% ▲ |
| PL | 8,516 | 48 | 177 | +94.7% ▲ |
| DN | 8,427 | 77 | 109 | +20.1% ▲ |
Top Prescribing Practices
| Practice | Items |
|---|---|
| MODALITY PARTNERSHIP (AWC) | 1,567 |
| VIDA HEALTHCARE | 1,457 |
| PRIORY MEDICAL GROUP | 1,122 |
BNF Classification
- Chapter: Malignant Disease and Immunosuppression
- Section: Sex hormones and hormone antagonists in malignant disease
- Paragraph: Hormone antagonists
Related drugs in this section
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.